Related references
Note: Only part of the references are listed.Single-Nucleotide Polymorphism and Copy Number Variation of the Multidrug Resistance-1 Locus of Plasmodium vivax: Local and Global Patterns
Rosa del Carmen et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Comparative Ex Vivo Activity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax
Jutta Marfurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations
Shilpi Garg et al.
EXPERIMENTAL PARASITOLOGY (2012)
Plasmodium falciparum 19-Kilodalton Merozoite Surface Protein 1 (MSP1)-Specific Antibodies That Interfere with Parasite Growth In Vitro Can Inhibit MSP1 Processing, Merozoite Invasion, and Intracellular Parasite Development
David K. Moss et al.
INFECTION AND IMMUNITY (2012)
On the pathogenesis of Plasmodium vivax malaria: Perspectives from the Brazilian field
Fabio T. M. Costa et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2012)
Impact of pre-existing MSP142-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
Elke S. Bergmann-Leitner et al.
MALARIA JOURNAL (2012)
Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature
Marcus V. G. Lacerda et al.
MALARIA JOURNAL (2012)
Antimalarial Activity and Mechanisms of Action of Two Novel 4-Aminoquinolines against Chloroquine-Resistant Parasites
Anna Caroline Campos Aguiar et al.
PLOS ONE (2012)
Phase 1 Study in Malaria Naive Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria
Ruth D. Ellis et al.
PLOS ONE (2012)
An Analytical Method for Assessing Stage-Specific Drug Activity in Plasmodium vivax Malaria: Implications for Ex Vivo Drug Susceptibility Testing
Douglas H. Kerlin et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Prevalence of Drug Resistance-Associated Gene Mutations in Plasmodium vivax in Central China
Feng Lu et al.
KOREAN JOURNAL OF PARASITOLOGY (2012)
Resistance to Chloroquine Unhinges Vivax Malaria Therapeutics
J. Kevin Baird
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Strain-Transcending Fc-Dependent Killing of Plasmodium falciparum by Merozoite Surface Protein 2 Allele-Specific Human Antibodies
Janine Stubbs et al.
INFECTION AND IMMUNITY (2011)
Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
Susanne H. Sheehy et al.
MOLECULAR THERAPY (2011)
Identification of a Highly Antigenic Linear B Cell Epitope within Plasmodium vivax Apical Membrane Antigen 1 (AMA-1)
Lilian Lacerda Bueno et al.
PLOS ONE (2011)
A Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response
Graeme J. M. Cowan et al.
PLOS ONE (2011)
A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1
Kevin K. A. Tetteh et al.
VACCINE (2011)
Merozoite surface proteins of the malaria parasite: The MSP1 complex and the MSP7 family
Madhusudan Kadekoppala et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2010)
On the Cytoadhesion of Plasmodium vivax-Infected Erythrocytes
Bruna O. Carvalho et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay
Carmen Fernandez-Becerra et al.
MALARIA JOURNAL (2010)
Malaria in Brazil: an overview
Joseli Oliveira-Ferreira et al.
MALARIA JOURNAL (2010)
Severe Plasmodium vivax Malaria, Brazilian Amazon
Marcia A. Alexandre et al.
EMERGING INFECTIOUS DISEASES (2010)
Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay
Kazutoyo Miura et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Ric N. Price et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
Inhibition of Erythrocyte Invasion and Plasmodium falciparum Merozoite Surface Protein 1 Processing by Human Immunoglobulin G1 (IgG1) and IgG3 Antibodies
Maria Lazarou et al.
INFECTION AND IMMUNITY (2009)
Anti-MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele-Specific Manner by Monocyte-Mediated Antibody-Dependent Cellular Inhibition
Corine Demanga Galamo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Ivo Mueller et al.
LANCET INFECTIOUS DISEASES (2009)
Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific
Onome J. Akpogheneta et al.
INFECTION AND IMMUNITY (2008)
Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia:: Species-specific and cross-reactive responses
Tonia Woodberry et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum
Fiona J. McCallum et al.
PLOS ONE (2008)
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3
Christian Roussilhon et al.
PLOS MEDICINE (2007)
Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians
Melissa S. Bastos et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1
PA Nogueira et al.
INFECTION AND IMMUNITY (2006)
Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis
F Perandin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays
M Rougemont et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria
DR Cavanagh et al.
INFECTION AND IMMUNITY (2004)
Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus
C Putaporntip et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum
DR Cavanagh et al.
INFECTION AND IMMUNITY (2001)
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
DMN Okenu et al.
INFECTION AND IMMUNITY (2000)
Share Paper
